In humans, nicotinamide riboside (NR) is well tolerated and raises NAD+.
- Confidence
- Established
- Level of evidence
- Randomized clinical trial
- Observed in
- Human
- Mission
- Map of aging (12 hallmarks)
- Concepts
- Genomic instabilityNAD+ precursors (NMN, NR)
Each row is an article. “Supports”: it backs the claim. “Contradicts”: it goes against it. “Qualifies”: it limits it (another species, a weaker effect…).
| Direction | Source | Where in the article | Status |
|---|---|---|---|
| Supports | Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults Martens et al. · Nature Communications 2018 |
— | Verified |